Abstract
Decreased levels of caveolin promote sensitivity to androgen withdrawal in prostate cancer cells, suggesting another therapeutic target for the treatment of prostate cancer (pages 1062–1064).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Visakorpi, T. et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet. 9, 401–406 (1995).
Culig, Z. et al. Androgen receptor activation in prostate tumor cell lines by insulin–like growth factor–1, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474–5478 (1994).
Berges, R.B. et al. Implications of cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res. 1, 473–480 (1995).
Yang, G. et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 8, 1873 –1880 (1998).
Nasu, Y. et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen insensitive mouse prostate cancer cells. Nature Med. 4, 1062–1064 (1998).
Lisanti, M.P. et al. Characterization of caveolin–rich membrane domains isolated from an endothelial–rich source: Implications for human disease. J. Cell. Biol. 126, 111–126 (1994).
Koleske, A.J., Baltimore, D. & Lisanti, M.P. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA 92, 1381–1385 (1995).
Chun, M., Liyanage, U.K., Lisanti, M.P. & Lodish, H.F. Signal transduction of a G protein–coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91, 11728–11732 (1994).
Chun, M., Lin, H.Y., Henis, Y.I. & Lodish, H.F. Endothelin–induced endocytosis of cell surface ETA receptors: endothelin remains intact and bound to the ETA receptor. J. Biol. Chem. 270, 10855–10560 (1995).
Wu–Wong, J.R., Chiou, W.J., Dickinson, R. & Opgenorth, T.J. Endothelin attenuates apoptosis in human smooth muscle cells. Biochem. J. 328, 733–737 (1997).
Nelson, J.B. et al. Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Med. 1, 944–949 (1995).
Isaacs, J.T. Hormonally responsive versus unresponsive progression of prostatic cancer to anti–androgen therapy as studied with the Dunning R–3327–AT and –G rat adenocarcinomas. Cancer Res. 42, 5010–5014 (1982).
Yamada, E. The fine structures of the gall bladder epithelium of the mouse. J. Biophysic. Biochem. Cytol. 1, 445– 457 (1955).
Plato . In Plato's Republic Book VII. (translated by Grube, G.M.A.) 167– 191 (Hackett, Indianapolis, 1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nelson, J. Alternatives to death: Understanding androgen-independent prostate cancer . Nat Med 4, 1011–1012 (1998). https://doi.org/10.1038/1998
Issue Date:
DOI: https://doi.org/10.1038/1998
